Xingchen Peng
Clinical trials sponsored by Xingchen Peng, explained in plain language.
-
MRNA vaccine takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early study tests a new mRNA vaccine (IL-22BP) for people with advanced solid tumors like sarcoma, head and neck cancer, or melanoma that have not responded to standard treatments. The vaccine is injected directly into tumors. Only 6 participants are enrolled to check safety…
Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New app aims to fight malnutrition in cancer patients
Symptom relief Recruiting nowThis study tests a smartphone app designed to help cancer patients manage their nutrition. Researchers will enroll 84 people with cancer who are at risk for nutritional problems. Participants will use the app to track their diet and receive guidance from nutritionists, with the g…
Phase: NA • Sponsor: Xingchen Peng • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC